HBOX Therapies

04.11.2023

HBOX Therapies was selected as one of the most promising start-ups in Europe, thanks to our innovative product and robust business plan. This means we will receive a grant of €2.5M and a potential follow-on investment to further advance and commercialize our medical device MiRA. We are very proud and grateful for this achievement. We will continue working hard to make our vision a reality and to improve clinical outcomes.

About EIC Accelerator:
The EIC Accelerator is the cornerstone of the Horizon Europe funding programme (2021-2027) by the European Commission and the European Innovation Council (EIC). It is designed for small and medium-sized enterprises, mid-cap companies and individuals who need financial support to bring their novel ideas, technologies and products to the market.

About MiRA:
MiRA (Miniatuarized Respiratory Assist) is expected to become the first alternative to invasive mechanical ventilation for patients suffering from acute lung failure. MiRA aims to reduce complication rates and improve outcomes, offering a new treatment regime for millions of patients annually.

 

Link zum LinkedIn Post.

Diesen Artikel teilen

Gallerie

Ähnliche Themen

Testsieger bei Stiftung Warentest: heat it® überzeugt als einziges Produkt ohne Mängel

25.04.2025

Karlsruhe – In einem aktuellen Vergleich von 14 Insektenstichheilern durch die Stiftung Warentest belegt der smarte S...

Weiterlesen

Yuri startet Weltraum-Experiment zur nachhaltigen Proteinforschung

24.04.2025

Am 21. April 2025 wurde ein innovatives Ernährungsexperiment zur Internationalen Raumstation (ISS) gestartet. Durchge...

Weiterlesen

node.energy sammelt 15 Mio. Euro für Grünstrom-Plattform

24.04.2025

Das Frankfurter Team von node.energy hat in einer überzeichneten Series-B-Runde 15 Millionen Euro eingesammelt. Mit d...

Weiterlesen